Monday, February 17, 2014

17 Largest US Medical Laboratories & Research Company Stock Prices Down 46% Due to Financial Meltdown Spillover Effects, Then Up 215% Under Obama and the US Fed

I found 17 US Medical Laboratories & Research Companies classified in the Health Care Sector at Yahoo's superb Finance website with current Total Market Capitalizations of at least $100 mil and which also had their common stocks trading on each of the following three dates:

  • On December 31, 2007 during President Bush's second term
  • On March 6, 2009, very early in President Obama's first term, which was their lowest point due to the spillover effects resulting from the 2008 financial meltdown, and 
  • also on the most recent date February 14, 2014.

The historical common stock prices of these companies were obtained from the following two excellent internet resources....  Google Finance and MarketWatch Big Charts.

These 17 largest US Medical Laboratories & Research Companies had their average stock prices decline by a huge 46% from December 31, 2007 during President Bush's second Presidential term, to March 6, 2009, very early in President Obama's first term, which was the very lowest point for the overall stock market due to the spillover effects resulting from the disastrous 2008 Financial Meltdown.

But in the slightly less than five years since March 6, 2009, the average stock prices of these same 17 largest US Medical Laboratories & Research Companies have increased by a very respectable 215% through February 14, 2014.

16 of these 17 US Medical Laboratories & Research Companies experienced stock price increases since March 6, 2009.
 
Clearly, a majority of the investors in and employees of these 17 US Medical Laboratories & Research Companies must be pleased with the impact of actions taken by both the Obama Administration and the US Fed to successfully rescue the US economy from its extremely weakened state.

Also, all of these US Medical Laboratories & Research Companies are huge beneficiaries of the Affordable Care Act. 

Below here are the stock market prices of each of these 17 US Medical Laboratories & Research Companies on February 14, 2014, on March 6, 2009, and on  December 31, 2007:






Market Market






Price Price






% %






Change Change



Market Market Market 3-6-09 12-31-07



Price Price Price to to
Medical Laboratories & Research Company HQs
2-14-14 3-6-09 12-31-07 2-14-14 3-6-09







PAREXEL Intl Waltham MA       51.70         7.95       24.15 550% -67%
Mettler-Toledo Columbus OH      249.64       47.40      113.80 427% -58%
Neogenomics Fort Myers FL         3.74         0.75         1.08 399% -31%
TearLab San Diego CA         7.06         1.50         2.00 371% -25%
Psychemedics Acton MA       18.64         4.04       16.05 361% -75%
Agilent Technologies Santa Clara CA       55.25       12.65       36.74 337% -66%
PerkinElmer Waltham MA       43.98       11.52       26.02 282% -56%
Thermo Fisher Scientific Waltham MA      123.74       34.16       57.68 262% -41%
Covance Princeton NJ      102.34       34.50       86.62 197% -60%
Bio-Reference Laboratories Elmwood Park NJ       27.38       10.64       16.34 157% -35%
Bio-Rad Laboratories Hercules CA      131.59       54.97      103.62 139% -47%
Laboratory Corp America Burlington NC       91.94       54.99       75.53 67% -27%
Alere Waltham MA       35.12       21.97       56.18 60% -61%
Genomic Health Redwood City CA       27.62       19.57       22.64 41% -14%
Quest Diagnostics Madison NJ       52.60       44.41       52.90 18% -16%
Enzo Biochem New York NY         3.34         3.08       12.74 8% -76%
Alliance Healthcare Services Newport Beach CA       28.77       34.35       48.10 -16% -29%








Average % Change all 17




215% -46%